Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)
The provision of a vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 11.5 million doses of vaccine.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The opportunity is not split into lots.
Make the case to bid
Reveal who to approach at UK Health Security Agency, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- 663d64f7-1d56-4863-a5a6-c381800c9d72
- Stage
- pipeline · Closed
- Source
- Contracts Finder
- Buyer ref
- CF-2690900D0O000000rwimUAA
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
Assembling the market network…
UK Health Security Agency’s tender network
Assembling the network…
Similar open tenders
Measles, Mumps and Rubella (MMR) vaccine (2027)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Staff Flu Vaccination Programme
Hull City Council